CHAMP1-Related Neurodevelopmental Disorder: Two Turkish Cases with Novel Truncating Variants and Literature Review
Molecular Syndromology · 12.03.2026 · 1-9
DOI: 10.1159/000551451 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Syndromology, online erschienen am 12.03.2026. Verfasst von Zehra Manav Yigit und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
CHAMP1-related neurodevelopmental disorder (CHAMP1-NDD; neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features; MIM: 616579) is a rare autosomal-dominant condition caused by de novo truncating variants leading to haploinsufficiency. The phenotype is characterized by global developmental delay, intellectual disability, severe speech impairment, hypotonia, distinctive craniofacial features, and variable multisystem involvement. Case Presentation: We describe two unrelated girls harboring novel de novo truncating CHAMP1 variants. Both presented with global developmental delay, profound speech impairment, hypotonia, postnatal growth impairment, and characteristic craniofacial features. Neuroimaging demonstrated normal findings in 1 patient and a thin corpus callosum in the other. Additional manifestations included high-grade vesicoureteral reflux in one individual and sensory dysregulation, reduced pain sensitivity, early-onset hyperphagia, and recurrent respiratory infections in the other. Perinatal complications were noted in one case; however, the overall phenotype was considered primarily attributable to the underlying genetic diagnosis. Exome sequencing identified heterozygous truncating variants, NM_032436.4:c.2081_2082del; p.Ser694* and NM_032436.4:c.2062dup; p.Glu688Glyfs*8, both confirmed as de novo and classified as likely pathogenic according to American College of Medical Genetics and Genomics (ACMG) criteria.
Conclusion
These cases expand the mutational spectrum of CHAMP1 and further delineate the phenotypic variability of this disorder, highlighting under-recognized systemic and behavioral features. Recognition of these additional clinical observations may facilitate earlier diagnosis and multidisciplinary management, although further studies in larger cohorts are required to clarify their clinical relevance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye.
- Department of Medical Genetics, Istanbul Haseki Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye.
- Department of Pediatrics, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
- Department of Pediatric Neurology, Faculty of Medicine, Biruni University, Istanbul, Türkiye.
Zitieren
APA
Manav Yigit, Z., Ozyavuz Cubuk, P., Bayrak, K. U., Duz, M. B., & Yuksel, A. (2026). CHAMP1-Related Neurodevelopmental Disorder: Two Turkish Cases with Novel Truncating Variants and Literature Review. Molecular Syndromology, 1-9. https://doi.org/10.1159/000551451
Vancouver
Manav Yigit Z, Ozyavuz Cubuk P, Bayrak KU, Duz MB, Yuksel A. CHAMP1-Related Neurodevelopmental Disorder: Two Turkish Cases with Novel Truncating Variants and Literature Review. Molecular Syndromology. 2026:1-9. doi:10.1159/000551451
BibTeX
@article{ManavYigit2026,
author = {Manav Yigit, Zehra and Ozyavuz Cubuk, Pelin and Bayrak, Kamil Utku and Duz, Mehmet Bugrahan and Yuksel, Adnan},
title = {CHAMP1-Related Neurodevelopmental Disorder: Two Turkish Cases with Novel Truncating Variants and Literature Review},
journal = {Molecular Syndromology},
year = {2026},
pages = {1--9},
doi = {10.1159/000551451}
}
EUVIMED